Monthly Archives: February 2012

How to use an Epipen

Posted in Uncategorized | Leave a comment

Study: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

http://clinicaltrials.gov/ct2/show/NCT01522820 Purpose This phase I trial studies the side effects and best schedule of vaccine therapy when given together with or without sirolimus in treating patients with NY-ESO-1 expressing solid tumors. Biolo… Continue reading

Posted in Uncategorized | Leave a comment

Bone-density diagnoses are complicated

http://www.dispatch.com/content/stories/local/2012/02/26/to-your-health/bone-density-diagnoses-are-complicated.html 02-27-12 Rita Price – The Columbus Dispatch, Ohio Continue reading

Posted in Uncategorized | Leave a comment

Central role of IL-6 and MMP-1 for cross talk between human intestinal mast cells and human intestinal fibroblasts

http://www.sciencedirect.com/science/article/pii/S017129851200006X (excerpts follow) Immunobiology. 2012 Jan 4, Montier Y, Lorentz A, Kr??mer S, Sellge G, Schock M, Bauer M, Schuppan D, Bischoff SC, Dept of Nutritional Medicine, U of Hohenheim, Stu… Continue reading

Posted in Uncategorized | Leave a comment

UVA1 Phototherapy: A Concise and Practical Review

http://www.skintherapyletter.com/download/stl_17_1.pdf Skin Therapy Lett. 2012 Jan;17(1):1-3, Zandi S, Kalia S, Lui H, Psoriasis and Phototherapy Clinic, Vancouver Gen Hospital; Dept of Dermatology and Skin Science, U of British Columbia, Canada; … Continue reading

Posted in Uncategorized | Leave a comment

Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: Implication for the pathogenesis of interstitial cystitis/bladder pain syndrome

http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2042.2012.02966.x/abstract (excerpts follow) Int J Urol. 2012 Feb 21, Furuta A, Suzuki Y, Hayashi N, Egawa S, Yoshimura N, Dept of Urology, Jikei U Dept of Urology, Tokyo Rehabilitation Hospital, D… Continue reading

Posted in Uncategorized | Leave a comment

Reversal of Oxidative Stress by Histamine H3 Receptor-Ligands in Experimental Models of Schizophrenia

https://www.thieme-connect.com/DOI/DOI?10.1055/s-0031-1301326 (excerpts below) Arzneimittelforschung. 2012 Feb 13, Mahmood D, Khanam R, Pillai KK, Akhtar M, Dept of Pharmacology, Hamdard U, India Oxidative injuries contribute enormously to the pat… Continue reading

Posted in Uncategorized | Leave a comment

The possible role of trauma in skin tags through the release of mast cell mediators

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=6;spage=641;epage=646;aulast=El (excerpt follows) Indian J Dermatol. 2011 Nov;56(6):641-6, El Safoury OS, Fawzy MM, Hay RM, Hassan AS, El Maadawi ZM, Rashed LA, Dermatology … Continue reading

Posted in Uncategorized | Leave a comment

Mast cell activation syndrome masquerading as agranulocytosis

http://www.ingentaconnect.com/search/article?option1=tka&value1=”Mast+cell+activation+syndrome+masquerading+as+agranulocytosis”&pageSize=10&index=1 Mil Med. 2012 Jan;177(1):113-7, Afrin LB, Section of Hematology/Oncology, Medical Service, Ralp… Continue reading

Posted in Uncategorized | Leave a comment

Substance P Signaling Controls Mast Cell Activation, Degranulation, and Nociceptive Sensitization in a Rat Fracture Model of Complex Regional Pain Syndrome

http://journals.lww.com/anesthesiology/Abstract/publishahead/Substance_P_Signaling_Controls_Mast_Cell.98899.aspx Anesthesiology. 2012 Feb 15, Li WW, Guo TZ, Liang DY, Sun Y, Kingery WS, Clark JD, * Senior Research Scientist, Physical Medicine and … Continue reading

Posted in Uncategorized | Leave a comment